Two Alzheimer’s drugs, lecanemab and donanemab, have been approved in the US. At a recent gathering organized by the Goulandris Foundation and the Hellenic Initiative Against Alzheimer’s, new research on lecanemab was presented.
AMWAJ Real Estate
Two Alzheimer’s drugs, lecanemab and donanemab, have been approved in the US. At a recent gathering organized by the Goulandris Foundation and the Hellenic Initiative Against Alzheimer’s, new research on lecanemab was presented.